Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus

被引：36

作者：

Dubee, Vincent ^{[1
,2
,3
,4
]}

Soroka, Daria ^{[1
,2
,3
]}

Cortes, Melanie ^{[1
,2
,3
]}

Lefebvre, Anne-Laure ^{[1
,2
,3
]}

Gutmann, Laurent ^{[1
,2
,3
,5
]}

Hugonnet, Jean-Emmanuel ^{[1
,2
,3
]}

Arthur, Michel ^{[1
,2
,3
]}

Mainardi, Jean-Luc ^{[1
,2
,3
,5
]}

机构：

[1] INSERM, LRMA, Ctr Rech Cordeliers, Equipe 12,UMR S 1138, Paris, France

[2] Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, Paris, France

[3] Univ Paris 05, Ctr Rech Cordeliers, Sorbonne Paris Cite, UMR S 1138, Paris, France

[4] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France

[5] Hop Europeen Georges Pompidou, AP HP, Paris, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 05期

关键词：

MASSILIENSE; CEPHALOSPORIN; INFECTIONS; ACID;

D O I：

10.1128/AAC.05080-14

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The production of beta-lactamases BlaMab and BlaC contributes to beta-lactam resistance in Mycobacterium abscessus and Mycobacterium tuberculosis, respectively. Ceftaroline was efficiently hydrolyzed by these enzymes. Inhibition of M. tuberculosis BlaC by clavulanate decreased the ceftaroline MIC from >= 256 to 16 to 64 mu g/ml, but these values are clinically irrelevant. In contrast, the ceftaroline-avibactam combination should be evaluated against M. abscessus since it inhibited growth at lower and potentially achievable drug concentrations.

引用

页码：2938 / 2941

页数：4

共 50 条

[21] Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
Mukherjee, Devika
Wu, Mu-Lu
Teo, Jeanette W. P.
Dick, Thomas
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
[22] Understanding the Structure, Activity and Inhibition of Chorismate Synthase from Mycobacterium tuberculosis
Arcuri, H. A.
Palma, M. S.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (09) : 1311 - 1317
[23] Natural Terpenes Influence the Activity of Antibiotics against Isolated Mycobacterium tuberculosis
Sieniawska, Elwira
Swatko-Ossor, Marta
Sawicki, Rafal
Skalicka-Wozniak, Krystyna
Ginalska, Grazyna
MEDICAL PRINCIPLES AND PRACTICE, 2017, 26 (02) : 108 - 112
[24] Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating Mycobacterium abscessus
Berube, Bryan J.
Castro, Lina
Russell, Dara
Ovechkina, Yulia
Parish, Tanya
FRONTIERS IN MICROBIOLOGY, 2018, 9
[25] Surface Dependent Inhibition of Mycobacterium abscessus by Diverse Pseudomonas aeruginosa Strains
Idosa, Ayantu W.
Wozniak, Daniel J.
Hall-Stoodley, Luanne
MICROBIOLOGY SPECTRUM, 2022, 10 (06):
[26] Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species
Jong, Bor-En
Wu, Ting-Shu
Chen, Nan-Yu
Yang, Cheng-How
Shu, Chin-Chung
Wang, Lih-Shinn
Wu, Tsu-Lan
Lu, Jang-Jhih
Chiu, Cheng-Hsun
Lai, Hsin-Chih
Chung, Wen-Hung
MICROBIOLOGY SPECTRUM, 2022, 10 (06):
[27] Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus
Lopeman, Rose C.
Harrison, James
Rathbone, Daniel L.
Desai, Maya
Lambert, Peter A.
Cox, Jonathan A. G.
SCIENTIFIC REPORTS, 2020, 10 (01)
[28] An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus
Zhang, Kaixi
Limwongyut, Jakkarin
Moreland, Alex S.
Wei, Samuel Chan Jun
Min, Tania Jim Jia
Sun, Yan
Shin, Sung Jae
Kim, Su-Young
Jhun, Byung Woo
Pethe, Kevin
Bazan, Guillermo C.
SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (735)
[29] GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus
De Groote, Mary Ann
Johnson, Laura
Podell, Brendan
Brooks, Elizabeth
Basaraba, Randall
Gonzalez-Juarrero, Mercedes
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) : 1057 - 1064
[30] Novel Synthetic Peptide Agelaia-12 Has Improved Activity Against Mycobacterium abscessus Complex
Coelho, Arthur Alves
Barbosa, Lilia Cristina de Souza
da Costa, Adeliane Castro
Kipnis, Andre
Junqueira-Kipnis, Ana Paula
PATHOGENS, 2024, 13 (11):

← 1 2 3 4 5 →